Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | DCN |
| Upstream (Parents) |
|---|
| (<<) HEG1 → DCN |
| (<<) GUCY1A3 → DCN |
| (<<) SNAI2 → DCN |
| (<<) PCOLCE → DCN |
| (<<) LUM → DCN |
| (<<) LHFP → DCN |
| Downstream (Children) |
|---|
| DCN → GLI1 (>>) |
| DCN → EML1 (>>) |
| DCN → LYZL6 (>>) |
| DCN → HEG1 (>>) |
| DCN → COL21A1 (>>) |
| DCN → PLXND1 (>>) |
| DCN → GUCY1A3 (>>) |
| DCN → ATP10D (>>) |
| DCN → WWTR1 (>>) |
| DCN → SNAI2 (>>) |
| DCN → PTPRM (>>) |
| DCN → PCOLCE (>>) |
| DCN → ZEB1 (>>) |
| DCN → VCAM1 (>>) |
| DCN → CAV1 (>>) |
| DCN → SRPX (>>) |
| DCN → GRK6 (>>) |
| DCN → NRP1 (>>) |
| DCN → GAS1 (>>) |
| DCN → SPARCL1 (>>) |
| DCN → BMP1 (>>) |
| DCN → LHFP (>>) |
| DCN → RARB (>>) |
| DCN → FHL1 (>>) |
| DCN → EVC (>>) |
| DCN → NUP188 (>>) |
| DCN → FLRT2 (>>) |
